Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 061935/0217 | |
| Pages: | 8 |
| | Recorded: | 12/01/2022 | | |
| Attorney Dkt #: | P11362US00 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17768441
|
Filing Dt:
|
04/12/2022
|
|
Publication #:
|
|
Pub Dt:
|
03/16/2023
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION COMPRISING POLYNUCLEOTIDES AND USE THEREOF FOR PREVENTION OR TREATMENT OF COVID-19
|
|
|
Assignees
|
|
|
|
|
| ROOM 101, 1/F, BUILDING 2, NO. 38 YONGDA ROAD DAXING BIO-PHARMACEUTICAL INDUSTRIAL BASE |
| ZHONGGUANCUN SCIENCE PARK, DAXING DISTRICT |
| BEIJING, CHINA 102600 |
|
|
|
|
|
| DAXIN 2 VILLAGE, CAILUO TOWN |
| XINCHENGZI DISTRICT |
| SHENYANG, LIAONING, CHINA 110131 |
|
|
Correspondence name and address
|
| |
PERRY + CURRIER
|
| |
1300 YONGE STREET
|
| |
SUITE 500
|
| |
TORONTO, M4T 1X3 CANADA
|
Search Results as of:
05/27/2024 10:22 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
